246 related articles for article (PubMed ID: 8691473)
61. Design, synthesis, and antihyperlipidemic evaluation of novel 2-[1-(substitutedphenyl)-4-oxo-azetidin-2-yl]-5,6-disubstitutedthieno[2,3-d]pyrimidin-4(3H)-ones.
Arya N; Munde MK; Dwivedi J; Jagdale AY; Jain KS
Arch Pharm (Weinheim); 2013 Aug; 346(8):588-95. PubMed ID: 23881664
[TBL] [Abstract][Full Text] [Related]
62. [Quinazolinones. 3. Synthesis, pharmacology and structure-activity relationship of derivatives of 2-methyl-3-(4-oxo-3-phenyl-thiazolidin-2-ylidenamino)-4(3H) -quinazolinone].
Büyüktimkin S
Arch Pharm (Weinheim); 1985 Jun; 318(6):496-501. PubMed ID: 4026543
[No Abstract] [Full Text] [Related]
63. Non-steroidal anti-inflammatory agents: novel pyrazolyl-, 1,2-oxazolyl-, and 1,3-diazinyl derivatives of 4(3H)-quinazolinones.
Khalil MA; Soliman R; Farghaly AM; Bekhit AA
Arch Pharm (Weinheim); 1994 Jan; 327(1):27-30. PubMed ID: 8117186
[TBL] [Abstract][Full Text] [Related]
64. Hypolipidaemic activity of a novel acyclic ansamycin derivative. Synthesis and pharmacokinetic and pharmacodynamic studies in rodents.
Menear KA; Dunnet KE; Hastewell JG; Eichler HG; Gibson JC; Kimble EF; Kump W; Taylor PW
Arzneimittelforschung; 1992 Sep; 42(9):1125-9. PubMed ID: 1445480
[TBL] [Abstract][Full Text] [Related]
65. Synthesis and antihyperlipidemic activity of novel coumarin bisindole derivatives.
Sashidhara KV; Kumar A; Kumar M; Srivastava A; Puri A
Bioorg Med Chem Lett; 2010 Nov; 20(22):6504-7. PubMed ID: 20932744
[TBL] [Abstract][Full Text] [Related]
66. Microwave-assisted synthesis, hypolipidemic and hypoglycemic activity of some novel 2-(4-(2-Amino-6-(4-substituted phenyl)-pyrimidin-4-yl)-phenoxy)-2-methyl propanoic acid derivatives.
Mokale SN; Elgire RD; Sakle NS; Shinde DB
Arch Pharm (Weinheim); 2012 Jan; 345(1):22-7. PubMed ID: 22076967
[TBL] [Abstract][Full Text] [Related]
67. Design, synthesis and in vivo screening of some novel quinazoline analogs as anti-hyperlipidemic and hypoglycemic agents.
Mokale SN; Palkar AD; Dube PN; Sakle NS; Miniyar PB
Bioorg Med Chem Lett; 2016 Jan; 26(2):272-276. PubMed ID: 26707395
[TBL] [Abstract][Full Text] [Related]
68. Preparation and biological activity of some 2-substituted 3-(4'carboxyphenyl)-7-nitro-4 (3H)-quinazolinones.
Varma RS; Bahadur S; Agnihotri AK
Pol J Pharmacol Pharm; 1980; 32(5):801-6. PubMed ID: 7271941
[TBL] [Abstract][Full Text] [Related]
69. [Beclobrate and eniclobrate hydrochloride, new diphenylmethane derivatives as agents for lowering cholesterol and triglyceride levels. Part I: Synthesis and consideration of structure-activity relationships (author's transl)].
Thiele K; Ahmed Q; Jahn U; Adrian RW
Arzneimittelforschung; 1979; 29(5):711-20. PubMed ID: 582967
[TBL] [Abstract][Full Text] [Related]
70. Synthesis and biological activity of certain derivatives of 2,4-dioxo-1,2,3,4-tetrahydroquinazoline. Part 2.
Khalifa M; Osman AN; Ibrahim MG; el Rahman A; Ossman E; Ismail MA
Pharmazie; 1982 Feb; 37(2):115-7. PubMed ID: 6978491
[TBL] [Abstract][Full Text] [Related]
71. Synthesis of novel benzocoumarin derivatives as lipid lowering agents.
Sashidhara KV; Rosaiah JN; Kumar A; Bhatia G; Khanna AK
Bioorg Med Chem Lett; 2010 May; 20(10):3065-9. PubMed ID: 20399654
[TBL] [Abstract][Full Text] [Related]
72. [Synthesis of potential CCK antagonist quinazolone derivatives].
Szabó M; Kökösi J; Orfi L
Acta Pharm Hung; 1995 Jul; 65(4):133-8. PubMed ID: 7572196
[TBL] [Abstract][Full Text] [Related]
73. Potential hypolipidemic agents. XI. Synthesis, plasma lipid-lowering properties and bioavailability of some esters of 2-(4-dibenzofuranoloxy)-2-methylpropionic acid.
Bondesson G; Högberg T; Magnusson O; Stjernström NE
Acta Pharm Suec; 1975; 12(4):361-74. PubMed ID: 1199735
[No Abstract] [Full Text] [Related]
74. Synthesis of 2,4-diaminoquinazolines and tricyclic quinazolines by cascade reductive cyclization of methyl N-cyano-2-nitrobenzimidates.
Yin P; Liu N; Deng YX; Chen Y; Deng Y; He L
J Org Chem; 2012 Mar; 77(6):2649-58. PubMed ID: 22283399
[TBL] [Abstract][Full Text] [Related]
75. Synthesis and antihyperlipidemic activity of some novel condensed 2-chloroalkyl-4-chloro/hydroxy-5,6-disubstituted pyrimidines.
Kathiravan MK; Shishoo CJ; Kumar KG; Roy SK; Mahadik KR; Kadam SS; Jain KS
Arzneimittelforschung; 2007; 57(9):599-606. PubMed ID: 17966759
[TBL] [Abstract][Full Text] [Related]
76. [Synthesis and antibacterial as well as antineoplastic activities of 2,4-diamino-5-methyl-6-(N-methyl-substituted benzyl) aminoquinazolines].
Meng XY; Zhang XP; Chen XH; Yu AZ
Yao Xue Xue Bao; 1991; 26(5):383-6. PubMed ID: 1957691
[TBL] [Abstract][Full Text] [Related]
77. Potential hypolipidemic agents. XVII. Synthesis and plasma lipid-lowering properties of compounds related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate and ethyl 2-(4-chlorophenoxy)-2-methylpropionate.
Högberg T; Bondesson G; Stjernström NE
Acta Pharm Suec; 1977; 14(2):149-60. PubMed ID: 906832
[No Abstract] [Full Text] [Related]
78. Antihypertensive pyrrolo[1,2-c]quinazolines and pyrrolo[1,2-c]quinazolinones.
Bandurco VT; Wong EM; Levine SD; Hajos ZG
J Med Chem; 1981 Dec; 24(12):1455-60. PubMed ID: 7310823
[TBL] [Abstract][Full Text] [Related]
79. Non-steroidal antiinflammatory agents. Synthesis of novel 2-pyrazolyl-4(3H)-quinazolinones.
Farghaly AM; Chaaban I; Khalil MA; Bekhit AA
Arch Pharm (Weinheim); 1990 Oct; 323(10):833-6. PubMed ID: 2080894
[TBL] [Abstract][Full Text] [Related]
80. Design, synthesis and bronchodilatory activity of a series of quinazoline-3-oxides.
Combs DW; Rampulla MS; Russell RK; Rampulla RA; Klaubert DH; Ritchie D; Meeks AS; Kirchner T
Drug Des Deliv; 1990 Oct; 6(4):241-54. PubMed ID: 2083028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
